Clinical importance of VEGFC and PD-L1 co-expression in lung adenocarcinoma patients

Qin, TT; Xia, JL; Liu, SC; Wang, J; Liu, HL; Zhang, Y; Jia, YN; Li, K

Li, K (corresponding author), Tianjin Med Univ, Tianjin Canc Inst & Hosp, Tianjin Lung Canc Ctr, Dept Thorac Oncol, Tianjin 300060, Peoples R China.

THORACIC CANCER, 2020; 11 (5): 1139

Abstract

Background Vascular endothelial growth factor C (VEGFC), an activator of lymphangiogenesis, is newly identified as an immunomodulator which can regula......

Full Text Link